[Relation between Helicobacter pylori and atopic diseases]

Gerardo López Pérez1, Fernando Alcántara Rodríguez

  • 1Servicio de Alergia, Instituto Nacional de Pediatria, Insurgentes Sur 2700-A, Col. Insurgentes Cuicuilco, CP 04530 México DF. api3@prodigy.net.mx

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|December 28, 2002
PubMed

Insights

While infections may increase atopic diseases, the study found no direct link between Helicobacter pylori and allergies. Further research is needed to clarify its indirect role and potential treatment implications.

Area of Science:

  • Immunology
  • Microbiology
  • Allergology

Background:

  • Atopic diseases and infections are rising.
  • Infections can cause chronic inflammation and mast cell sensitization, leading to allergies.
  • Helicobacter pylori is a proposed bacterial agent linked to atopic diseases.

Purpose of the Study:

  • To review the scientific literature on the relationship between Helicobacter pylori infection and allergic diseases.
  • To determine if a direct causal link exists.
  • To explore potential indirect roles and future research directions.

Main Methods:

  • Bibliographical review of existing studies.
  • Analysis of evidence linking Helicobacter pylori to allergic conditions.
  • Assessment of the role of chronic inflammation and mast cell sensitization.

Main Results:

  • No direct causal evidence was found linking Helicobacter pylori infection to allergic diseases.
  • Helicobacter pylori may play an indirect role in the development or exacerbation of allergies.
  • The chronic inflammatory processes initiated by infections are key factors.

Conclusions:

  • Current evidence does not support a direct causal relationship between Helicobacter pylori and allergies.
  • Further controlled and randomized studies are essential to accurately define this relationship.
  • Helicobacter pylori eradication could be a potential therapeutic strategy for allergic patients, pending further evidence.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...